Sun Young Rha

35.5k citations
717 papers · 18.3k · 6 hit papers · h-index 63

Impact in

    • Gastric Cancer Management and Outcomes
    • Renal cell carcinoma treatment
    • Sarcoma Diagnosis and Treatment
  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies

Papers in

    • Gastric Cancer Management and Outcomes 171
    • Renal cell carcinoma treatment 98
    • Lung Cancer Treatments and Mutations 47
    • Colorectal Cancer Treatments and Studies 80
    • HER2/EGFR in Cancer Research 47
    • Cancer Immunotherapy and Biomarkers 47

Sun Young Rha

689 papers receiving 18.0k citations

Sun Young Rha's Hit Papers

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial 2023 · 246 citations
2460+5+10Years since publication250500750

Peers

Sun Young Rha
Comparison fields: 5 of 157
  • Pulmonary and Respiratory Medicine 7.3k
  • Oncology 5.9k
  • Gastroenterology 896
  • Cancer Research 2.2k
  • Molecular Biology 4.8k
Replace Manish A. Shah with:
Manish A. Shah United States
Lin Shen China
Jiafu Ji China
John J. Crowley United States
David P. Kelsen United States
Stefano Cascinu Italy
Hye Seung Lee South Korea
Atsushi Ochiai Japan
Manisha H. Shah United States
Stefan Sleijfer Netherlands
Sun Young Rha relative to Manish A. Shah United States Manish A. Shah's profile →
Citations per field
00.5×1.5×
Manish A. Shah · 1×
Citations per year

Countries citing papers authored by Sun Young Rha

Since Specialization
Citations

This map shows the geographic impact of Sun Young Rha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun Young Rha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun Young Rha more than expected).

Fields of papers citing papers by Sun Young Rha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sun Young Rha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun Young Rha. The network helps show where Sun Young Rha may publish in the future.

Co-authors

The 25 scholars most cited alongside Sun Young Rha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sun Young Rha Line = papers co-authored together Sun Young Rha links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 717 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Hit paper breakdown →
2011852
2
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
Hit paper breakdown →
2013742
3
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2016547
4 1999460
5 2007408
6
Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Hit paper breakdown →
2014313
7
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Hit paper breakdown →
2015290
8
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Hit paper breakdown →
2023246
9 2017226
10 2013185
11 2007181
12 2015180
13 2011173
14 2013172
15 2008145
16 2012139
17 2016126
18 2016121
19 2008116
20 2013114

About Sun Young Rha

Sun Young Rha is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Cancer Research, having authored 717 papers that have together received 18.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (171 papers), Renal cell carcinoma treatment (98 papers), Colorectal Cancer Treatments and Studies (80 papers), Cancer Genomics and Diagnostics (52 papers), HER2/EGFR in Cancer Research (47 papers), Cancer Immunotherapy and Biomarkers (47 papers), Lung Cancer Treatments and Mutations (47 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (34 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.3k citations), Oncology (5.9k citations), Gastroenterology (896 citations), Cancer Research (2.2k citations) and Molecular Biology (4.8k citations). Sun Young Rha has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Hyun Cheol Chung, Hei‐Cheul Jeung, Sung Hoon Noh, Joong Bae Ahn, Jae Kyung Roh, Hyo Song Kim, Toni K. Choueiri, Lori Wood, Frede Donskov and Brian I. Rini. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research and Treatment, Cancer Research and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact